| # | Side effect | Count |
|---|---|---|
| 0 | PRODUCT USE IN UNAPPROVED INDICATION | 294 |
| 1 | OFF LABEL USE | 170 |
| 2 | LIVER ABSCESS | 73 |
| 3 | PYREXIA | 59 |
| 4 | PULMONARY EMBOLISM | 49 |
| 5 | PRODUCT USE ISSUE | 43 |
| 6 | ASPARTATE AMINOTRANSFERASE INCREASED | 40 |
| 7 | PANCYTOPENIA | 36 |
| 8 | ALANINE AMINOTRANSFERASE INCREASED | 35 |
| 9 | DISEASE PROGRESSION | 33 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | VENOUS INTRAVASATION | 5 | 0.3333 |
| 1 | URINE IODINE INCREASED | 8 | 0.3333 |
| 2 | LIPOGRANULOMA | 4 | 0.3077 |
| 3 | HEPATIC ARTERY STENOSIS | 30 | 0.2308 |
| 4 | POST EMBOLISATION SYNDROME | 24 | 0.2087 |
| 5 | HEPATIC ARTERY OCCLUSION | 11 | 0.1294 |
| 6 | BILOMA | 18 | 0.1277 |
| 7 | GOITRE CONGENITAL | 4 | 0.1111 |
| 8 | HYPOTHYROIDIC GOITRE | 3 | 0.1111 |
| 9 | BLOOD BETA-D-GLUCAN ABNORMAL | 2 | 0.1000 |